Review: Hydroxyoctadecadienoic acids: Novel regulators of macrophage differentiation and atherogenesis

Therapeutic Advances in Endocrinology and Metabolism

Volumn 1, Issue 2, 2010, Pages 51-60

  Vangaveti, Venkat ^a   Baune, Bernhard T ^a   Kennedy, R Lee ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

atherosclerosis; diabetes; G protein coupled receptors; oxidative stress; oxidized lipids

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 9 HYDROXYOCTADECADIENOIC ACID; ABC TRANSPORTER A1; ARACHIDONATE 15 LIPOXYGENASE; CD36 ANTIGEN; FATTY ACID BINDING PROTEIN 4; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR BI; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR RISK; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; STROKE;

EID: 79952855112     PISSN: 20420188     EISSN: None     Source Type: Journal    
DOI: 10.1177/2042018810375656     Document Type: Review

References (64)

1. Barlic, J. and Murphy, P.M. ( 2007) An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion. Trends Cardiovasc Med 17: 269-274.
2. Barlic, J., Zhang, Y., Foley, J.F. and Murphy, P.M. ( 2006) Oxidized lipid-driven chemokine receptor switch, CCR 2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation 114: 807-819.
3. Bertomeu, M.C., Crozier, G.L., Haas, T.A., Fleith, M. and Buchanan, M.R. ( 1990) Selective effects of dietary fats on vascular 13-HODE synthesis and platelet/vessel wall interactions. Thromb Res 59: 819-830.
4. Bolick, D.T., Skaflen, M.D., Johnson, L.E., Kwon, S.C., Howatt, D., Daugherty, A. et al (2009) G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ Res 104: 318-327.
5. Bolick, D.T., Whetzel, A.M., Skaflen, M., Deem, T.L., Lee, J. and Hedrick, C.C. ( 2007) Absence of the G protein-coupled receptor G2A in mice promotes monocyte/endothelial interactions in aorta. Circ Res 100: 572-580.
6. Bouhlel, M.A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S. et al (2007) PPARgamma activation primes human monocytes into alternative M 2 macrophages with anti-inflammatory properties. Cell Metab 6: 137-143.
7. Bouhlel, M.A., Staels, B. and Chinetti-Gbaguidi, G. ( 2008) Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J Intern Med 263: 28-42.
8. Brinckmann, R. and Kuhn, H. ( 1997) Regulation of 15-lipoxygenase expression by cytokines. Adv Exp Med Biol 400B: 599-604.
9. Bull, A.W., Branting, C., Bronstein, J.C., Blackburn, M.L. and Rafter, J. ( 1993) Increases in 13-hydroxyoctadecadienoic acid dehydrogenase activity during differentiation of cultured cells. Carcinogenesis 14: 2239-2243.
10. Cabrero, A., Cubero, M., Llaverias, G., Jove, M., Planavila, A., Alegret, M. et al (2003) Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Metabolism 52: 652-657.
11. Carpenter, K.L., Taylor, S.E., van der Veen, C., Williamson, B.K., Ballantine, J.A. and Mitchinson, M.J. (1995) Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta 1256: 141-150.
12. Chinetti, G., Griglio, S., Antonucci, M., Torra, I.P., Delerive, P., Majd, Z. et al (1998) Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580.
13. Cho, Y. and Ziboh, V.A. ( 1994) Incorporation of 13-hydroxyoctadecadienoic acid (13-HODE) into epidermal ceramides and phospholipids: phospholipase C-catalyzed release of novel 13-HODE-containing diacylglycerol. J Lipid Res 35: 255-262.
14. Coene, M.C., Bult, H., Claeys, M., Laekeman, G.M. and Herman, A.G. ( 1986) Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acid. Thromb Res 42: 205-214.
15. Daret, D., Blin, P., Dorian, B., Rigaud, M. and Larrue, J. ( 1993) Synthesis of monohydroxylated fatty acids from linoleic acid by rat aortic smooth muscle cells and tissues: influence on prostacyclin production. J Lipid Res 34: 1473-1482.
16. Daret, D., Blin, P. and Larrue, J. ( 1989) Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. Prostaglandins 38: 203-214.
17. de Graaf, J.C., Bult, H., de Meyer, G.R., Sixma, J.J. and de Groot, P.G. ( 1989) Platelet adhesion to sub-endothelial structures under flow conditions: no effect of the lipoxygenase product 13-HODE. Thromb Haemost 62: 802-806.
18. Delerive, P., Furman, C., Teissier, E., Fruchart, J., Duriez, P. and Staels, B. ( 2000) Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett 471: 34-38.
19. Fu, Y., Luo, N. and Lopes-Virella, M.F. ( 2000) Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res 41: 2017-2023.
20. Fu, Y., Luo, N., Lopes-Virella, M.F. and Garvey, W.T. ( 2002) The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 165: 259-269.
21. Fu, Y., Luo, L., Luo, N. and Garvey, W.T. ( 2006) Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis 188: 102-111.
22. Gron, B., Iversen, L., Ziboh, V. and Kragballe, K. ( 1993a) Distribution of monohydroxy fatty acids in specific human epidermal phospholipids. Exp Dermatol 2: 38-44.
23. Gron, B., Iversen, L., Ziboh, V. and Kragballe, K. ( 1993b) Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin. Arch Dermatol Res 285: 449-454.
24. Haas, T.A., Bastida, E., Nakamura, K., Hullin, F., Admirall, L. and Buchanan, M.R. ( 1988) Binding of 13-HODE and 5-, 12- and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim Biophys Acta 961: 153-159.
25. Haas, T.A., Bertomeu, M.C., Bastida, E. and Buchanan, M.R. ( 1990) Cyclic AMP regulation of endothelial cell triacylglycerol turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenicity. Biochim Biophys Acta 1051: 174-178.
26. Hampel, J.K.A., Brownrigg, L.M., Vignarajah, D., Croft, K.D., Dharmarajan, A.M., Bentel, J.M. et al (2006) Differential modulation of cell cycle, apoptosis and PPARgamma 2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins Leukot Essent Fatty Acids 74: 283-293.
27. Hardwick, S.J., Hegyi, L., Clare, K., Law, N.S., Carpenter, K.L., Mitchinson, M.J. et al (1996) Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J Pathol 179: 294-302.
28. Hattori, T., Obinata, H., Ogawa, A., Kishi, M., Tatei, K., Ishikawa, O. et al (2008) G2A plays proinflammatory roles in human keratinocytes under oxidative stress as a receptor for 9-hydroxyoctadecadienoic acid. J Invest Dermatol 128: 1123-1133.
29. Jira, W., Spiteller, G., Carson, W. and Schramm, A. ( 1998) Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids 91: 1-11.
30. Jostarndt, K., Gellert, N., Rubic, T., Weber, C., Kuhn, H., Johansen, B. et al (2002) Dissociation of apoptosis induction and CD 36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells. Biochem Biophys Res Commun 290: 988-993.
31. Jostarndt, K., Rubic, T., Kuhn, H., Anthosen, M.W., Andera, L., Gellert, N. et al (2004) Enzymatically modified low-density lipoprotein upregulates CD 36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way. Biochem Pharmacol 67: 841-854.
32. Kaduce, T.L., Figard, P.H., Leifur, R. and Spector, A.A. ( 1989) Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J Biol Chem 264: 6823-6830.
33. Kuhn, H., Belkner, J., Wiesner, R., Schewe, T., Lankin, V.Z. and Tikhaze, A.K. ( 1992) Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids 5: 17-22.
34. Kuhn, H., Belkner, J., Zaiss, S., Fahrenklemper, T. and Wohlfeil, S. ( 1994) Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 179: 1903-1911.
35. Lim, H.J., Lee, S., Lee, K.S., Park, J.H., Jang, Y., Lee, E.J. et al (2006) PPARgamma activation induces CD 36 expression and stimulates foam cell like changes in rVSMCs. Prostaglandins Other Lipid Mediat 80: 165-174.
36. Limor, R., Sharon, O., Knoll, E., Many, A., Weisinger, G. and Stern, N. ( 2008) Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens 21: 219-223.
37. Mahipal, S.V., Subhashini, J., Reddy, M.C., Reddy, M.M., Anilkumar, K., Roy, K.R. et al (2007) Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochem Pharmacol 74: 202-214.
38. Mani, I., Iversen, L. and Ziboh, V.A. ( 1998) Upregulation of nuclear PKC and MAP-kinase during hyperproliferation of guinea pig epidermis: modulation by 13-(S)-hydroxyoctadecadienoic acid (13-HODE). Cell Signal 10: 143-149.
39. Marx, N., Bourcier, T., Sukhova, G.K., Libby, P. and Plutzky, J. ( 1999) PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19: 546-551.
40. Miller, C.C. and Ziboh, V.A. ( 1990) Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-hode). J Invest Dermatol 94: 353-358.
41. Muellner, M.K., Schreier, S.M., Laggner, H., Hermann, M., Esterbauer, H., Exner, M. et al (2009) Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem J 420: 277-281.
42. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H. and Evans, R.M. ( 1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240.
43. Obinata, H., Izumi, T., Obinata, H. and Izumi, T. (2009) G2A as a receptor for oxidized free fatty acids. Prostaglandins Other Lipid Mediat 89: 66-72.
44. Parks, B.W., Gambill, G.P., Lusis, A.J. and Kabarowski, J.H.S. ( 2005) Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J Lipid Res 46: 1405-1415.
45. Parks, B.W., Srivastava, R., Yu, S., Kabarowski, J.H., Parks, B.W., Srivastava, R. et al (2009) ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 29: 539-547.
46. Ramboer, I., Blin, P., Lacape, G., Daret, D., Lamaziere, J.M. and Larrue, J. ( 1992) Effects of monohydroxylated fatty acids on arterial smooth muscle cell properties. Kidney Int Suppl 37: S67-S72.
47. Rikitake, Y., Hirata, K.-I., Yamashita, T., Iwai, K., Kobayashi, S., Itoh, H. et al (2002) Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22: 2049-2053.
48. Rusinol, A.E., Yang, L., Thewke, D., Panini, S.R., Kramer, M.F. and Sinensky, M.S. ( 2000) Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J Biol Chem 275: 7296-7303.
49. Setty, B.N., Berger, M. and Stuart, M.J. ( 1987) 13-Hydroxyoctadecadienoic acid (13-HODE) stimulates prostacyclin production by endothelial cells. Biochem Biophys Res Commun 146: 502-509.
50. Stoll, L.L., Morland, M.R. and Spector, A.A. ( 1994) 13-HODE increases intracellular calcium in vascular smooth muscle cells. Am J Physiol 266: C990-C996.
51. Tloti, M.A., Moon, D.G., Weston, L.K. and Kaplan, J.E. ( 1991) Effect of 13-hydroxyoctadeca-9,11-dienoic acid (13-HODE) on thrombin induced platelet adherence to endothelial cells in vitro. Thromb Res 62: 305-317.
52. Truitt, A., McNeill, G. and Vanderhoek, J.Y. ( 1999) Antiplatelet effects of conjugated linoleic acid isomers. Biochim Biophys Acta 1438: 239-246.
53. Upston, J.M., Neuzil, J., Witting, P.K., Alleva, R. and Stocker, R. ( 1997) Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, alpha-tocopherol-mediated peroxidation of cholesteryl esters. J Biol Chem 272: 30067-30074.
54. Waddington, E., Sienuarine, K., Puddey, I. and Croft, K. ( 2001) Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal Biochem 292: 234-244.
55. Waddington, E.I., Croft, K.D., Sienuarine, K., Latham, B. and Puddey, I.B. ( 2003) Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 167: 111-120.
56. Wang, D., Strandgaard, S., Iversen, J., Wilcox, C.S., Wang, D., Strandgaard, S. et al (2009) Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 296: R195-R200.
57. Weber, E., Haas, T.A., Muller, T.H., Eisert, W.G., Hirsh, J., Richardson, M. et al (1990) Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenicity following injury: influence of salicylate and dipyridamole treatment. Thromb Res 57: 383-392.
58. Weng, Z., Fluckiger, A.C., Nisitani, S., Wahl, M.I., Le, L.Q., Hunter, C.A. et al (1998) A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc Natl Acad Sci U S A 95: 12334-12339.
59. Wintergerst, E.S., Jelk, J., Rahner, C. and Asmis, R. ( 2000) Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD 36 and activation of caspase-3. Eur J Biochem 267: 6050-6059.
60. Wittwer, J. and Hersberger, M. ( 2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77: 67-77.
61. Xie, S., Lee, Y.F., Kim, E., Chen, L.M., Ni, J., Fang, L.Y. et al (2009) TR 4 nuclear receptor functions as a fatty acid sensor to modulate CD 36 expression and foam cell formation. Proc Natl Acad Sci USA 106: 13353-13358.
62. Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F. et al (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328-12338.
63. Yoshida, Y., Kodai, S., Takemura, S., Minamiyama, Y., Niki. and E. ( 2008) Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 379: 105-115.
64. Zhao, L., Funk, C.D., Zhao, L. and Funk, C.D. ( 2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 14: 191-195.